These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24338492)

  • 1. Leptin in chronic kidney disease: a link between hematopoiesis, bone metabolism, and nutrition.
    Zhang J; Wang N
    Int Urol Nephrol; 2014 Jun; 46(6):1169-74. PubMed ID: 24338492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Increased Serum Leptin with Ameliorated Anemia and Malnutrition in Stage 5 Chronic Kidney Disease Patients after Parathyroidectomy.
    Jiang Y; Zhang J; Yuan Y; Zha X; Xing C; Shen C; Shen Z; Qin C; Zeng M; Yang G; Mao H; Zhang B; Yu X; Sun B; Ouyang C; Xu X; Ge Y; Wang J; Zhang L; Cheng C; Yin C; Zhang J; Chen H; Ma H; Wang N
    Sci Rep; 2016 Jun; 6():27918. PubMed ID: 27307101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of peripheral serotonin on leptin-brain serotonin axis, bone metabolism and strength in growing rats with experimental chronic kidney disease.
    Pawlak D; Domaniewski T; Znorko B; Oksztulska-Kolanek E; Lipowicz P; Doroszko M; Karbowska M; Pawlak K
    Bone; 2017 Dec; 105():1-10. PubMed ID: 28797891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin and chronic kidney diseases.
    Mao S; Fang L; Liu F; Jiang S; Wu L; Zhang J
    J Recept Signal Transduct Res; 2018 Apr; 38(2):89-94. PubMed ID: 29388492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral Adipose Tissue and Leptin Hyperproduction Are Associated With Hypogonadism in Men With Chronic Kidney Disease.
    Cobo G; Cordeiro AC; Amparo FC; Amodeo C; Lindholm B; Carrero JJ
    J Ren Nutr; 2017 Jul; 27(4):243-248. PubMed ID: 28366446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin as an uremic toxin: Deleterious role of leptin in chronic kidney disease.
    Alix PM; Guebre-Egziabher F; Soulage CO
    Biochimie; 2014 Oct; 105():12-21. PubMed ID: 25010649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Causes and Potential Injurious Effects of Elevated Serum Leptin Levels in Chronic Kidney Disease Patients.
    Korczynska J; Czumaj A; Chmielewski M; Swierczynski J; Sledzinski T
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-renal-Related Mechanisms of FGF23 Pathophysiology.
    Hanudel MR; Laster M; Salusky IB
    Curr Osteoporos Rep; 2018 Dec; 16(6):724-729. PubMed ID: 30353318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone mineral metabolism in patients with chronic kidney disease: review of its pathophysiology and morbimortality].
    Bernuy J; Gonzales GF
    Rev Peru Med Exp Salud Publica; 2015; 32(2):326-34. PubMed ID: 26338395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocytokines in Patients with Chronic Kidney Disease Stage 5.
    Yahya RS; Atwa MA; El-Sayed IH; El-Ghanaam DM; Hussein DT; El-Taweel FA
    Clin Lab; 2016; 62(1-2):21-30. PubMed ID: 27012030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts and management strategies in chronic kidney disease-mineral and bone disorder.
    Chauhan V; Kelepouris E; Chauhan N; Vaid M
    South Med J; 2012 Sep; 105(9):479-85. PubMed ID: 22948328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin and ghrelin in chronic kidney disease: their associations with protein-energy wasting.
    Canpolat N; Sever L; Agbas A; Tasdemir M; Oruc C; Ekmekci OB; Caliskan S
    Pediatr Nephrol; 2018 Nov; 33(11):2113-2122. PubMed ID: 29980850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Leptin and dyslipidemia in chronic kidney disease.
    Noor S; Alam F; Fatima SS; Khan M; Rehman R
    Pak J Pharm Sci; 2018 May; 31(3):893-897. PubMed ID: 29716870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder)].
    Iwashita Y; Iwashita Y; Ito T; Shigematsu T
    Clin Calcium; 2016 Feb; 26(2):259-67. PubMed ID: 26813506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse Effects of the Metabolic Acidosis of Chronic Kidney Disease.
    Kraut JA; Madias NE
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):289-297. PubMed ID: 29031355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Plasma Concentration of Klotho Protein, Osteocalcin, Leptin, Adiponectin, and Bone Mineral Density in Patients with Chronic Kidney Disease.
    Marchelek-Mysliwiec M; Wisniewska M; Nowosiad-Magda M; Safranow K; Kwiatkowska E; Banach B; Dołegowska B; Dołegowska K; Stepniewska J; Domanski L; Pawlik A; Ciechanowski K
    Horm Metab Res; 2018 Nov; 50(11):816-821. PubMed ID: 30396210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic kidney disease and nutrition].
    Yoshida T; Kumagai H
    Clin Calcium; 2016 Mar; 26(3):369-74. PubMed ID: 26923973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone and Nutrition. Nutrition care of renal osteodystrophy].
    Tanaka S; Ito M
    Clin Calcium; 2015 Jul; 25(7):1057-62. PubMed ID: 26119320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anemia and bone disease of chronic kidney disease: pathogenesis, diagnosis, and management.
    Shemin D
    R I Med J (2013); 2014 Dec; 97(12):24-7. PubMed ID: 25463623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affect of serum leptin on nutritional status in renal disease.
    Norton PA
    J Am Diet Assoc; 2002 Aug; 102(8):1119-25. PubMed ID: 12171457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.